Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-14, Stock:JNJ, The news for the past five days is as follows:
2018-09-07: NEWS1: Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS2: Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS3: Pharma Stock Roundup: NVS&apos; Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS4: How Tesaro Hopes to Tackle Lung Cancer.NEWS5: How Tesaro Hopes to Tackle Lung Cancer.NEWS6: Lilly, Teva, Pfizer & Others Await FDA Decisions in September.NEWS7: How Tesaro Hopes to Tackle Lung Cancer.NEWS8: What Intuitive Surgical’s Valuation Trend Indicates.NEWS9: J&J to work with India on compensation for recalled hip implants.
2018-09-10: NEWS1: Shire's ADHD Portfolio Remains Strong Amid Competition.NEWS2: Shire's ADHD Portfolio Remains Strong Amid Competition.NEWS3: Shire&apos;s ADHD Portfolio Remains Strong Amid Competition.NEWS4: Notable Monday Option Activity: JNJ, BA, QCOM.NEWS5: Notable Monday Option Activity: JNJ, BA, QCOM.NEWS6: See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks.NEWS7: See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks.NEWS8: Dow Analyst Moves: JNJ.NEWS9: Dow Analyst Moves: JNJ.NEWS10: Most Analysts Currently Call Boston Scientific a ‘Buy’.NEWS11: The Week Ahead: Apple's Special Event, Mobile World Congress, US Inflation Data On Deck.NEWS12: Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod.NEWS13: Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod.NEWS14: Novartis a Top Ranked SAFE Dividend Stock With 3.6% Yield.NEWS15: Novartis a Top Ranked SAFE Dividend Stock With 3.6% Yield.NEWS16: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.NEWS17: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.NEWS18: Perrigo&apos;s OTC Version of Diarrhea Drug Imodium Gets FDA Nod.NEWS19: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.
2018-09-11: NEWS1: Alcon to Set Up Future Global Headquarters in Geneva.NEWS2: 12 Top Stock Picks to Shield Your Portfolio.NEWS3: Geron Corporation: A Sober Assessment.NEWS4: Geron Corporation: A Sober Assessment.NEWS5: Geron Corporation: A Sober Assessment.NEWS6: See what the IHS Markit Score report has to say about Johnson & Johnson..
2018-09-12: NEWS1: Geron Corp: Lost in Translation?.NEWS2: Geron Corp: Lost in Translation?.NEWS3: Geron Corp: Lost in Translation?.NEWS4: Geron: One of the Best-Performing Biotech Stocks in Past Month.
2018-09-13: NEWS1: 5 Dow Jones Stocks That Are Gaining New Ground.NEWS2: Allergan Unveils Spotlyte, Its First Digital Ventures Launch.NEWS3: Noteworthy ETF Inflows: QUAL, JNJ, V, XOM.NEWS4: Noteworthy ETF Inflows: QUAL, JNJ, V, XOM.NEWS5: City of Boston sues drugmakers over opioid epidemic.NEWS6: Johnson & Johnson Seeks EU and US Label Expansion for Darzalex.NEWS7: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2018.NEWS8: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2018.NEWS9: What Analysts Project for Thermo Fisher.NEWS10: Johnson & Johnson: Analyst Recommendations and Target Price.NEWS11: These 13 Stocks Have Raised Their Dividends for 50 Straight Years.NEWS12: Thermo Fisher to Acquire BDX’s Advanced Bioprocessing Business.

Answer: Decrease